OS Therapies Statistics

Total Valuation

OS Therapies has a market cap or net worth of $36.03 million. The enterprise value is $34.17 million.

Market Cap	36.03M
Enterprise Value	34.17M

Important Dates

The last earnings date was Friday, November 15, 2024, before market open.

Earnings Date	Nov 15, 2024
Ex-Dividend Date	n/a

Share Statistics

OS Therapies has 20.88 million shares outstanding. The number of shares has decreased by -6.42% in one year.

Current Share Class	20.88M
Shares Outstanding	20.88M
Shares Change (YoY)	-6.42%
Shares Change (QoQ)	+165.35%
Owned by Insiders (%)	17.84%
Owned by Institutions (%)	0.72%
Float	16.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	235.49
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.76

Current Ratio	0.76
Quick Ratio	0.72
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.13

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-237.78%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.85M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	2.91
200-Day Moving Average	n/a
Relative Strength Index (RSI)	19.04
Average Volume (20 Days)	24,931

Short Selling Information

The latest short interest is 8,931, so 0.04% of the outstanding shares have been sold short.

Short Interest	8,931
Short Previous Month	n/a
Short % of Shares Out	0.04%
Short % of Float	0.05%
Short Ratio (days to cover)	0.01

Income Statement

Revenue	n/a
Gross Profit	-5,154
Operating Income	-5.00M
Pretax Income	n/a
Net Income	-7.42M
EBITDA	-5.00M
EBIT	-5.00M
Earnings Per Share (EPS)	-$0.76

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	1.86M
Total Debt	n/a
Net Cash	1.86M
Net Cash Per Share	$0.09
Equity (Book Value)	-707,127
Book Value Per Share	-0.03
Working Capital	-613,787

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$5.78 million and capital expenditures $19, giving a free cash flow of -$5.78 million.

Operating Cash Flow	-5.78M
Capital Expenditures	19
Free Cash Flow	-5.78M
FCF Per Share	-$0.28

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OS Therapies does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	6.42%
Shareholder Yield	6.42%
Earnings Yield	-20.59%
FCF Yield	-16.04%

Analyst Forecast

The average price target for OS Therapies is $21.00, which is 1,117.39% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.00
Price Target Difference	1,117.39%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2